Boehringer Ingelheim completes $76M expansion of pet vaccine plant in Georgia

Boehringer Ingelheim completed a $76 million investment at its Athens, Georgia site, doubling capacity to produce vaccines for pets.

“Boehringer Ingelheim, a leading provider of animal health products for pets and livestock, marked the completion of work Wednesday after a $76 million investment in its site in Athens, Ga.”prnewswire.com

• 1 source
• prnewswire.comBoehringer Ingelheim Completes Plant Expansion After $76 Million Georgia InvestmentBoehringer IngelheimOct 9, 2019

Summarized from public sources; check the original articles before acting on it.